TScan Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:TCRX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
23 Sep 24	BuyUS$26,450	Barbara Klencke	Individual	5,000	US$5.29
26 Aug 24	BuyUS$56,100	Barbara Klencke	Individual	10,000	US$5.69
23 Aug 24	SellUS$43,361	Zoran Zdraveski	Individual	7,500	US$5.78
19 Dec 23	BuyUS$142,456	Timothy Barberich	Individual	29,147	US$4.97
14 Dec 23	BuyUS$25,400	Barbara Klencke	Individual	5,000	US$5.08

Insider Buying: TCRX insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.8%.

Top 25 shareholders own 92.02% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.3%	Baker Bros. Advisors LP	7,061,380	US$35.6m	0%	0.27%
9.86%	Lynx1 Capital Management LP	5,224,600	US$26.3m	0%	10.59%
9.44%	EcoR1 Capital, LLC	5,000,000	US$25.2m	0%	0.78%
8.42%	BlackRock, Inc.	4,462,352	US$22.5m	163%	no data
8.31%	Adage Capital Management, L.P.	4,400,000	US$22.2m	12.8%	0.04%
5.64%	BVF Partners L.P.	2,989,474	US$15.1m	0%	0.37%
4.72%	Cormorant Asset Management, LP	2,500,000	US$12.6m	0%	0.64%
4.13%	K2 Healthventures Equity Trust LLC	2,186,854	US$11.0m	0%	no data
4.03%	The Vanguard Group, Inc.	2,133,613	US$10.8m	18%	no data
3.93%	Pitango Venture Capital	2,079,985	US$10.5m	0%	13.74%
2.35%	Deer Management Company, LLC	1,245,504	US$6.3m	0%	0.54%
2.03%	GV Management Company, LLC	1,077,080	US$5.4m	0%	0.37%
1.98%	Simplify Asset Management Inc.	1,046,916	US$5.3m	0%	0.4%
1.96%	Propel Bio Management, LLC	1,040,223	US$5.2m	0%	7.28%
1.78%	Great Point Partners, LLC	940,831	US$4.7m	0%	0.89%
1.7%	Geode Capital Management, LLC	900,499	US$4.5m	118%	no data
1.6%	StemPoint Capital LP	845,069	US$4.3m	0%	1.18%
1.26%	Dean Capital Investments Management, LLC	665,563	US$3.4m	0%	2.59%
1.26%	LMR Partners LLP	665,529	US$3.4m	0%	0.09%
1.15%	State Street Global Advisors, Inc.	608,085	US$3.1m	350%	no data
0.91%	Invesco Capital Management LLC	482,454	US$2.4m	-1.22%	no data
0.67%	Paradigm Biocapital Advisors LP	353,886	US$1.8m	0%	0.06%
0.58%	Marshall Wace LLP	307,487	US$1.5m	60.8%	no data
0.55%	abrdn plc	292,144	US$1.5m	46.1%	no data
0.45%	Morgan Stanley, Investment Banking and Brokerage Investments	238,096	US$1.2m	6.34%	no data